Back Stocks profile

Stock analysis tool for investors

Asarfi Hospital Ltd.

NSE: 16550692 | BSE:543943

₹73.99 1.79 (2.48%) 1D

Diversified Consumer Services

Open an Account with Bigul in 5 minutes

Performance

Today’s low

69.20

Today’s High

75.80

52W low

55.50

52W High

145.80

Open Price

75.80

Prev. Close

59.6500

Volume

50000.00

Value

3699500.00

Fundamentals

Market Cap

145.60

Price to Earnings

0.00

Price to Book Value

2.10

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM

0.00

Net Profit TTM

0.00

Cash From Operating Activity

26.07

Return on Equity %

5.91

EMA & SMA

Bullish Moving Averages

12

Bearish Moving Averages

4

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

100

Week

100

Month

100

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

72.98

PIVOT

First Resistance

76.82

Second Resistance

79.64

Third Resistance

83.48

First Support

70.16

Second Support

66.32

Third Support

63.50

Relative Strength Index

64.33

Money Flow Index

70.63

MACD

0.71

MACD Signal

-1.14

Average True Range

3.65

Average Directional Index

22.09

Rate of Change (21)

20.31

Rate of Change (125)

-12.65

Commodity Channel Index

251.2

Williams %R

-10.2

BETA

1 Month

0.58

3 Month

0.31

1 Year

3 Year

PRICE CHANGE ANALYSIS

15.94%

1 Week

Low

High

60.63

75.81

23.32%

1 Month

Low

High

57

75.81

-12.4%

3 Months

Low

High

57

88.6

-23.23%

6 Months

Low

High

55.5

106.5

%

1 Year

Low

High

55.5

145.75

Bigul
04 Jul 2024

Asarfi Hospital Ltd - 543943 - Disclosure Of The Impact Of Audit Qualifications On Asarfi Hospital Limited Standalone & Consolidated Financial Statements.

We hereby submit the impact of audit qualifications standalone & consolidated financial statement as on 31st March''2024.
Bigul
22 Jun 2024

Asarfi Hospital Ltd - 543943 - Announcement Under Regulation 30 Of LODR Regulation, 2015 Regarding Board Comment On SDD Non-Compliance

The board of director of the company here confirmed that the company has internally complied with the regulation and also that a database is maintained by the company which is password protected.
Bigul
19 Jun 2024

Asarfi Hospital Ltd - 543943 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Outcome of Board Meeting for starting of Asarfi Cancer Institute unit and apply for subsidy for Asarfi cancer Institute Unit.
Bigul
13 Jun 2024

Asarfi Hospital Ltd - 543943 - IMPACT ON AUDIT QUALIFICATION FOR THE YEAR ENDED 31 MARCH, 2024

IMPACT ON AUDIT QUALIFICATION - STANDLONE AND CONSOLIDATED FOR THE YEAR ENDED 31 MARCH, 2024
Bigul
13 Jun 2024

Asarfi Hospital Ltd - 543943 - IMPACT ON AUDIT QUALIFICATION FOR THE YEAR ENDED 31 MARCH, 2024

IMPACT ON AUDIT QUALIFICATION - STANDLONE AND CONSOLIDATED FOR THE YEAR ENDED 31 MARCH, 2024
Bigul
06 Jun 2024

Asarfi Hospital Ltd - 543943 - Intimation Relating To Disposal Of Appeal Filed (Civil Appeal 6781-6782 / 2023) In Hon'Ble Supreme Court Of India In Favour Of Asarfi Hospital Limited Filed Against The Order Of The Hon'Ble High Court In FA 43 Of 2012 Relating To Land Allotted By State Of Jharkhand For Establishment Of Cancer Hospital.

We would like to inform you that an appeal was filed in Hon''ble Supreme Court of India against the Order dated 30.06.2022 passed by Hon''ble High Court in First Appeal Case No.43 of 2012. The case was listed in Hon''ble Supreme Court of India on 26.04.2024 for hearing and the Hon''ble Supreme Court has ruled in favor of Asarfi Hospital Limited by allowing the appeal and remanded the case back to the lower court for fresh adjudication
Bigul
09 May 2024

Asarfi Hospital Ltd - 543943 - Audited Results For 31.03.2024

Outcome of Board Meeting held on 6th May 2024 and Submission of Audited Financial Results for the year ended 31st March 2024 as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Bigul
06 May 2024

Asarfi Hospital Ltd - 543943 - Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May 2024 And Submission Of Unaudited Financial Results For The Half Year And Year Ended 31St March 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform you that the Board of Directors of Asarfi Hospital Limited (the Company), at its meeting held today i.e. on 6th May, 2024 has considered and approved the Unaudited Financial Results of the Company for the half year and year ended 31st March, 2024.
Bigul
29 Apr 2024

Asarfi Hospital Ltd - 543943 - Board Meeting Intimation for Adopting The Unaudited Financial Results For The Half Year And Year Ending 31 March 2024.

Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 ,inter alia, to consider and approve the unaudited financial results for the half year and year ending 31 March 2024.
Bigul
29 Apr 2024

Asarfi Hospital Ltd - 543943 - Certificate Under Regulation 40(9) & (10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

We herewith enclosed certificate under regulation 40(9) & (10) of SEBI (Listing Obligation and Disclosure Requirements) Regulations,2015 from PCS for the year ended 31.03.2024
See all News

FAQs

The latest market price of Asarfi Hospital Ltd. on NSE was Rs. 73.99 as of today.

The opening share price of Asarfi Hospital Ltd. was Rs. 75.80 as of today.

The 52-week high share price of Asarfi Hospital Ltd. was Rs. 145.80.

The 52 week low share price of Asarfi Hospital Ltd. was Rs. 55.50.

Please find Corporate actions section for more details.

The PE ratio of Asarfi Hospital Ltd. is 0.00. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Asarfi Hospital Ltd..

Close

Let's Open Free Demat Account